Klass Russell Kevin's Form 4 filing
Zomedica Corp. (ZOMDF) · filed Aug 12, 2025
- Accession no.
- 0001654954-25-009402
- Filed
- Aug 12, 2025, 12:30 PM ET
- Trade date
- Aug 11, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market purchases total $19.5K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Klass Russell KevinCIK 0001999774 | Officer (Sr Vice President of Sales) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 11, 2025 | Common Stock, without par value | PPurchaseAcquired | +250,000 | $0.038 | +$9,500 | 3,950,030 | Direct | |
| Aug 11, 2025 | Common Stock, without par value | PPurchaseAcquired | +250,000 | $0.04 | +$10,000 | 4,200,030 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.